VR Adviser as of March 31, 2023
Portfolio Holdings for VR Adviser
VR Adviser holds 25 positions in its portfolio as reported in the March 2023 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Miragen Therapeutics (VRDN) | 13.4 | $69M | 2.7M | 25.44 | |
| Cogent Biosciences (COGT) | 10.3 | $53M | 4.9M | 10.79 | |
| Enliven Therapeutics (ELVN) | 9.5 | $49M | 2.2M | 21.90 | |
| Terns Pharmaceuticals (TERN) | 8.4 | $43M | 3.6M | 11.84 | |
| Pliant Therapeutics (PLRX) | 7.4 | $38M | 1.4M | 26.60 | |
| Ambrx Biopharma Sponsored Ads | 5.7 | $29M | 3.3M | 8.92 | |
| Gh Research Ordinary Shares (GHRS) | 5.5 | $28M | 3.5M | 7.99 | |
| Dice Therapeutics | 4.6 | $24M | 819k | 28.65 | |
| Kalvista Pharmaceuticals (KALV) | 4.5 | $23M | 2.9M | 7.86 | |
| Merus N V (MRUS) | 4.4 | $23M | 1.2M | 18.40 | |
| Celcuity (CELC) | 4.2 | $22M | 2.1M | 10.25 | |
| Aerovate Therapeutics (AVTE) | 3.3 | $17M | 834k | 20.17 | |
| Cabaletta Bio (CABA) | 3.2 | $16M | 2.0M | 8.27 | |
| Vectivbio Hldg Ord Shs | 3.1 | $16M | 1.9M | 8.51 | |
| Annexon (ANNX) | 2.4 | $12M | 3.2M | 3.85 | |
| Savara (SVRA) | 2.4 | $12M | 6.4M | 1.95 | |
| Milestone Pharmaceuticals (MIST) | 1.7 | $8.7M | 2.2M | 3.94 | |
| Aclaris Therapeutics (ACRS) | 1.6 | $8.4M | 1.0M | 8.09 | |
| Theseus Pharmaceuticals | 1.3 | $6.8M | 770k | 8.88 | |
| Trevi Therapeutics (TRVI) | 1.1 | $5.6M | 3.1M | 1.85 | |
| Fulcrum Therapeutics (FULC) | 0.7 | $3.7M | 1.3M | 2.85 | |
| Lyra Therapeutics (LYRA) | 0.4 | $1.9M | 924k | 2.01 | |
| Avalo Therapeutics Com New | 0.3 | $1.8M | 1.0M | 1.75 | |
| Rallybio Corp (RLYB) | 0.3 | $1.5M | 269k | 5.71 | |
| Affimed Therapeutics B V | 0.2 | $1.1M | 1.4M | 0.75 |
